All lobbying filings
SL STRATEGIES, LLC
SL STRATEGIES, LLC filed a Q3 report for SEQIRUS on October 20, 2026, reporting $45,000 in lobbying income.
Lobbying for SEQIRUS · pharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$45,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbyists on this filing
1
-
MARY MOODY JOHNSONPreviously held: U.S. Senate Committee on Health, Education, Labor and Pensions
Government bodies contacted
2
Lobbying activity
2
Fiscal Year 2027 HHS Appropriations bills
Policies impacting seasonal and pandemic influenza response